Objective: The paper is to study and analyze the treatment costs and structure of patients with coronary heart disease, and to detect medical service to reduce the treatment costs. Methods: A total of 4000 patients with coronary heart disease admitted to the Affiliated Hospital of Shandong University of Traditional Chinese Medicine from 2020 to 2021 were selected as subjects. Univariate and multiple regression analysis were performed on the treatment cost. Results: The per capita treatment cost of patients was 9,000 yuan, and the proportion of the total cost was ordered as medical service fee, drug fee and diagnosis fee. The results showed that the age, complications and long hospital stay were the factors increasing hospitalization cost. Conclusion: The highest proportion of treatment cost of patients with coronary heart disease is medical service fee. Drugs should be used rationally, and supervision of drug use should be strengthened to optimize the treatment cost and results.
Key words
coronary heart disease /
treatment costs /
influencing factors
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 《中国心血管健康与疾病报告2020》编写组.《中国心血管健康与疾病报告2020》要点解读[J].中国心血管杂志,2021,26(03):209-218.
[2] 吴迪,于泽洋,杨文月,等.异地就医冠心病患者住院费用的变化情况及影响因素分析[J].中国慢性病预防与控制,2022,30(3):231-234.
[3] 吴琼,甘明玉,周良荣,等.2016-2018年湖南省冠心病患者住院费用结构分析[J].湖南中医药大学学报,2021,41(1):147-150.
[4] 徐阅,刘黎明,满晓玮,等.基于SHA 2011的北京市冠心病治疗费用核算结果与分析[J].中国卫生经济,2020,39(9):38-40.
[5] 杨娜,戈小洁,叶佳欣,等.2013-2016年兰州市三级医院老年冠心病患者住院费用构成与影响因素分析[J].社区医学杂志,2020,18(8):622-626.
[6] 韩雪. 兰州市城区三级医院冠心病患者住院费用研究[D].兰州:兰州大学,2019.